The big play from a regulatory standpoint has to be healthcare in general and the drug stocks in particular. If it looks like, around Halloween [Oct. 31], Bush is going to win, I think the drug stocks will do very well. If it looks like Gore is going to win, there could be cloud over the sector. Gore's rhetoric, starting at the convention in L.A. until now, has been quite anti-business for many industries and that has been troubling for many investors.
Greg Valliere